
Keywords: Esophageal Cancer; Preneoplastic; Esophagus; BE; Barrett's esophagus; CI; confidence interval; EAC; esophageal adenocarcinoma; IFD; indefinite for dysplasia; IHC; immunohistochemistry; LGD; low-grade dysplasia; NDBE; non-dysplastic Barrett's esophagus